Bhubaneswar: SUM Hospital is all set to conduct the second phase of the human clinical trial of India’s indigenous COVID-19 vaccine Covaxin from next week.
The first phase trial was conducted with 375 volunteers. The vaccination here was conducted after the volunteers had undergone a rigorous screening procedure.
Covaxin, the vaccine being developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR) and the National Institute of Virology (NIV), was administered to several persons who had volunteered to be part of the trial, Principal Investigator of the trial process Dr E Venkat Rao informed.
The Indian Council for Medical Research (ICMR), which is collaborating with the pharma company for the development of the vaccine, has chosen 12 medical institutes of the country for conducting trials. IMS is another medical facility from Odisha chosen for the purpose.
New Delhi: A BJD delegation submitted a memorandum on variances in the votes cast in…
New Delhi: Bangladesh’s interim government on Monday sent a diplomatic note to India asking the…
Bhubaneswar: Indian Renewable Energy Development Agency Limited (IREDA) has sanctioned over Rs 3,000 crore for…
Raipur: In a significant observation, the Chhattisgarh High Court has said that engaging in sexual intercourse…
Cuttack: The Orissa High Court on Monday reportedly directed the state government to immediately fill…
Bhubaneswar: Over 40 youths, lured to Maldives with promises of lucrative jobs in a private…
This website uses cookies.